Buren advises the German based Evonik Industries AG on the signing of an agreement with US based One Equity Partners to acquire US based PeroxyChem.
The purchase price (enterprise value) for obtaining all shares in PeroxyChem is about $ 625 million. The transaction is scheduled to be completed by mid-2019, subject to approval by the appropriate authorities.
Evonik is one of the world’s leading specialty chemicals companies and supplies to manufacturers in various markets. Evonik is listed on the Frankfurt stock exchange.
With the acquisition of PeroxyChem, Evonik significantly strengthens its growth segment Resource Efficiency and is expanding its portfolio of environmentally friendly and high growth specialty applications.
Buren has advised Evonik on the Dutch legal aspects of this transaction.
To read the press release published by Evonik, please click here
In the wake of the developments concerning the COVID-19 / Coronavirus, BUREN has adjusted it’s policies to ensure that our services and responsiveness
In the future, new rules will apply to Foreign Direct Investments (“FDI”) in the European Union and the Netherlands
On the 25th of April we were honored and proud to have welcomed a delegation of the Ministry of Justice headed